We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$77.6B
AUM Growth
+$5.19B
Cap. Flow
+$4.38B
Cap. Flow %
5.65%
Top 10 Hldgs %
15.11%
Holding
3,002
New
251
Increased
1,435
Reduced
1,132
Closed
141

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$523M
2
MRK icon
Merck
MRK
+$243M
3
TSLA icon
Tesla
TSLA
+$188M
4
ADBE icon
Adobe
ADBE
+$159M
5
INFY icon
Infosys
INFY
+$150M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$143M
2
CI icon
Cigna
CI
+$133M
3
DAL icon
Delta Air Lines
DAL
+$121M
4
DIS icon
Walt Disney
DIS
+$120M
5
CSCO icon
Cisco
CSCO
+$113M

Sector Composition

Rank Sector Weight
1 Technology 24.8%
2 Financials 15.9%
3 Healthcare 13.33%
4 Consumer Discretionary 11.85%
5 Industrials 11.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLNK icon
2851
Blink Charging
BLNK
$86.7M
$14.5K ﹤0.01%
10,421
-8,096
-44% -$14.3K
STTK icon
2852
Shattuck Labs
STTK
$682M
$14.3K ﹤0.01%
11,814
-2,690
-19% -$3.33K
LYEL icon
2853
Lyell Immunopharma
LYEL
$351M
$12.8K ﹤0.01%
998
-4,858
-83% -$96.3K
VRCA icon
2854
Verrica Pharmaceuticals
VRCA
$88M
$10.1K ﹤0.01%
+1,444
New +$15.9K
OVID icon
2855
Ovid Therapeutics
OVID
$489M
$9.93K ﹤0.01%
+10,639
New +$11.9K
LNAI
2856
Lunai Bioworks
LNAI
$10.7M
$8.76K ﹤0.01%
+131
New +$8.69K
CDT icon
2857
CDT Equity Inc
CDT
$1.96M
– –
0
– –
IVVD icon
2858
Invivyd
IVVD
$198M
$8.46K ﹤0.01%
19,094
-1,206
-6% -$939
IAUX
2859
i-80 Gold Corp
IAUX
$1.47B
$6.57K ﹤0.01%
13,540
-921
-6% -$745
LYRA
2860
DELISTED
LYRA THERAPEUTICS INC
LYRA
$5.93K ﹤0.01%
574
-507
-47% -$5.58K
AILE
2861
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$4.7K ﹤0.01%
11,195
-14,435
-56% -$18.5K
ACDC icon
2862
ProFrac Holding
ACDC
$929M
– –
-130,549
Closed -$886K
ACRE
2863
Ares Commercial Real Estate
ACRE
$256M
– –
-10,963
Closed -$76.7K
ADVM
2864
DELISTED
Adverum Biotechnologies
ADVM
– –
-59,970
Closed -$421K
ALLO icon
2865
Allogene Therapeutics
ALLO
$725M
– –
-33,589
Closed -$94K
ANGI icon
2866
Angi Inc
ANGI
$186M
– –
-2,552
Closed -$65.8K
ANIK icon
2867
Anika Therapeutics
ANIK
$277M
– –
-30,692
Closed -$758K
AOSL icon
2868
Alpha and Omega Semiconductor
AOSL
$1.03B
– –
-11,825
Closed -$439K
APLT
2869
DELISTED
Applied Therapeutics
APLT
– –
-218,518
Closed -$1.86M
ARCT icon
2870
Arcturus Therapeutics
ARCT
$200M
– –
-12,078
Closed -$280K
ASPN icon
2871
Aspen Aerogels
ASPN
$522M
– –
-14,659
Closed -$406K
ASTE icon
2872
Astec Industries
ASTE
$991M
– –
-6,559
Closed -$209K
AVIR icon
2873
Atea Pharmaceuticals
AVIR
$402M
– –
-13,143
Closed -$44K
BABA icon
2874
Alibaba
BABA
$317B
– –
-5,537
Closed -$588K
BDTX icon
2875
Black Diamond Therapeutics
BDTX
$114M
– –
-15,692
Closed -$68.3K
113 114
115
116 117

Similar funds

CTC (Chicago Trading Company)
CTC (Chicago Trading Company) Chicago, Illinois $217B AUM 46.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

AQR Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, AQR Capital Management held 3,002 positions worth $77.6B, up 7.2% from $72.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

AQR Capital Management deployed $4.38B of net new capital in Q4 2024, opening 251 new positions and adding to 1,435 existing holdings. Its largest new stake was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $143M trimmed.

  • AQR Capital Management's largest Q4 2024 buy was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.
  • AQR Capital Management added most to Apple in Q4 2024, an estimated $523M increase.
  • AQR Capital Management's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $143M.
  • AQR Capital Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $5.41M.
  • AQR Capital Management's ten largest holdings make up 15% of its $77.6B portfolio in Q4 2024.
  • AQR Capital Management opened 251 new positions and closed 141 in Q4 2024.
  • AQR Capital Management's portfolio value rose 7.2% quarter-over-quarter to $77.6B.

Based on AQR Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.